This suggests that inflammatory factors such as tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) may be involved in the development of mood changes that are characteristic of clinical depression (García-García et al., 2022). Here, IL1B is linked to depressive symptom measurement.